Prolonged intermediate syndrome pue to prganophosphate poisoning by Khan, Nadeem Ullah et al.
eCommons@AKU
Department of Emergency Medicine Medical College, Pakistan
August 2012
Prolonged intermediate syndrome pue to
prganophosphate poisoning
Nadeem Ullah Khan
Aga khan University, nadeemullah.khan@aku.edu
Muhammad Junaid Patel
Aga Khan University
M. N.M. Hifath
Aga khan University
Saima Kamal
Aga khan University
Syed Ather Hussain
Aga khan University
Follow this and additional works at: http://ecommons.aku.edu/pakistan_fhs_mc_emerg_med
Part of the Chemicals and Drugs Commons, Emergency Medicine Commons, and the Infectious
Disease Commons
Recommended Citation
Khan, N., Patel, M. J., Hifath, M. N., Kamal, S., Hussain, S. A. (2012). Prolonged intermediate syndrome pue to prganophosphate
poisoning. Journal of clinical toxicology, 2(4), 1-2.
Available at: http://ecommons.aku.edu/pakistan_fhs_mc_emerg_med/91
Open Access
Khan et al., 2:4
http://dx.doi.org/10.4172/scientificreports.229
Case Report Open Access
Open Access Scientific Reports
Scientific Reports
Open Access
Volume 2 • Issue 4 • 2012
Key words: Organophosphate; Poisoning; Intermediate syndrome; 
Pakistan Prolonged
Introduction
Organophosphate (OP) pesticide contributes significantly to 
morbidity and mortality related to poisoning in the developing world 
[1-3]. It generally present initially as acute cholinergic crisis which 
manifest as excessive salivation, lacrimation, sweating, vomiting, 
diarrhea, urination, pinpoint pupil, mental status changes and seizures. 
In some patient after acute cholinergic crisis is over an Intermediate 
syndrome of muscle weakness develops leading to respiratory failure 
[1-3]. Some cases have delayed complications like organophosphate 
induced delayed polyneuropathy and chronic organophosphate 
induced neuropsychiatric disorder. Most of the deaths occur during 
acute cholinergic crisis or during Intermediate syndrome of muscle 
weakness [3-5].
The incidence of Intermediate syndrome reported in literature 
varies and range from 8% - 84% of cases of organophosphate poisoning 
[3]. Various factor accounts for this difference, including the nature of 
OP compound, severity of poisoning and inadequate Oxime therapy 
etc. [3]. The syndrome occurs after the acute cholinergic crisis is over 
and patient is clinically improved. It manifests as acute muscle paralysis 
especially involving neck flexors, proximal muscles, cranial nerve palsy 
and respiratory muscles and therefore requires ventilator support [6]. 
Certain OP like parathion, methylparathion, malathion, and fenthion 
are commonly associated with this condition [6]. The recognition of 
this syndrome and its anticipation is important as apparently well 
patient suddenly develop respiratory failure leading to high morbidity 
and mortality.
We report a case of a 23 year old female with Organophosphate 
poisoning who was successfully treated with pralidoxime and atropine, 
in the acute phase of poisoning but suddenly developed respiratory 
failure that lasted for twenty three ICU days.
Case Report
A 23 year old young lady brought to the Emergency Department 
(ED) by family one hour after ingesting a bottle of an unknown 
insecticide. On arrival, she was having excessive secretion and multiple 
episodes of vomiting. She had 2 episodes of vomiting while in ED. 
On examination she was tachycardic and had pinpoint pupils. Patient 
was suspected to have organophosphate poisoning based on clinical 
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Abstract
Organophosphate poisoning can present as acute cholinergic syndrome, Intermediate syndrome and delayed 
neuropathy. Intermediate syndrome secondary to organophosphate poisoning is a serious health problem leading 
to increased morbidity and mortality. The incidence of problem varies and range from 8%-84% of organophosphate 
poisoning cases. The factors account for this difference is nature of organophosphate compound, severity of 
poisoning and inadequate Oxime therapy. The recognition of this syndrome is important as organophosphate 
poisoning is common in our country. We presented this case of organophosphate poisoning leading to prolonged 
intermediate syndrome. The muscle weakness associated with this syndrome generally resolves in 5-18 days but in 
our case this lasted for 23 days. After a prolonged Intensive Care Unit (ICU) stay patient was discharged home with 
no residual symptoms. The case highlights anticipation and recognition of this problem after cholinergic crisis is over.
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features. Nasogastric lavage was performed. She was also atropinized 
and started on pralidoxime. She was admitted to special care unit.
Her symptoms improved within 48 hours of treatment as she was 
planned to be shifted to general ward prior to discharge when she 
developed respiratory distress with peripheral cyanosis. Her pulse 
oximetry revealed hypoxia and she was started on high flow oxygen via 
facemask. She then developed an episode of Generalized Tonic Clonic 
seizures during which she was intubated and was shifted to ICU.
On improvement of her GCS in ICU it was noted that she had 
decreased power in her limbs. On examination she had objective 
weakness of all limbs (lower limbs greater than upper limbs) and deep 
tendon reflexes were depressed in upper and lower limbs. Cranial 
nerves and sensory examination were normal. Toxicology faculty at 
our institute diagnosed her as a case of Intermediate Syndrome (IMS).
Multiple attempts to extubate the patient failed due to persistent 
respiratory muscle weakness. She was also having excessive secretions 
requiring continuous infusion of atropine and pralidoxime. Her 
Electromyography (EMG) revealed significant decrement on fast 
frequency Repetitive Nerve Stimulation (RNS) consistent with 
neuromuscular junction disorder secondary to organophosphate 
poisoning. MRI brain with contrast and Lumbar puncture were normal. 
Her seizures were attributed to a recurrence of her childhood epilepsy 
by the neurologist and it was precipitated by hypoxia due to respiratory 
failure.
She stayed in ICU for 23 days and required a tracheostomy for 
successful weaning from ventilator and discharge from hospital. 
At follow up 6 weeks after discharge, she did not show any residual/
recurrence of her symptoms and her tracheostomy was removed.
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Discussion
Our case highlighted a prolonged duration of an intermediate 
syndrome requiring ICU and ventilator support for about 23 days. 
According to Gold frank’s toxicological emergencies [6], the muscle 
weakness, in general, resolves in 5 to 18 days, whereas this lasted 
longer in our case report. The maximum reported time of resolution 
in the literature is 30 days [3]. This is a huge burden on already scarce 
medical resources in the developing country. OP poisoning is common 
in developing world and regulation of pesticide control is not adequate 
in our country [2]. 
We also highlight through this case report that although 
organophosphate poisoning is common and published literature [2,7-9] 
is available from our country but we could not find a single case report or 
case series on this important entity from our country. Studies published 
on organophosphate poisoning from our country [2,7-9] has described 
clinical presentation of cholinergic excess, investigation, management 
and outcome of patient but no description of intermediate syndrome. 
Although hazardous pesticide is easily available in the market, the entity 
might be going unrecognized or unpublished. Therefore the risk as well 
as incidence in our setting is unknown. Recognition of the Intermediate 
syndrome will help us identify the risk existing in our community and 
thus will help plan intervention accordingly.
Recognition of signs of muscle weakness before full blown 
respiratory failure happens is also important. This patient developed 
shortness of breath initially then cyanosis and then followed by Tonic 
Clonic seizure. An assessment of muscle weakness at the time of 
complain of difficulty breathing would help avoid precipitating seizure 
episode. Another problem is inadequate labeling of pesticide product. 
The product ingested by patient was sold as pesticide but we could not 
identify the exact ingredient of the product as there was no labeling.
We generally treat these patients based on clinical finding of 
cholinergic excess in our setting. Labeling of product will help 
anticipating this important cause of morbidity and mortality. Banning 
of product associated with intermediate syndrome would be another 
desirable intervention.
Conclusion
Intermediate syndrome contributes to morbidity and mortality. 
Early recognition will help in prompt ventilator support. We 
recommend that patient with acute organophosphate poisoning should 
be assessed for muscle weakness after cholinergic crisis is over to 
anticipate impending respiratory arrest due to intermediate syndrome.
References
1. Aaron CK (2008) Organophosphate poisoning-induced intermediate syndrome: 
can electrophysiological changes help predict outcome? PLoS Medicine 5: 
1017-1018
2. Turabi A, Danyal A, Saud H, Durrani A, Ahmed M (2008) Organophosphate 
poisoning in the urban population; study conducted at National Poison control 
Centre, Karachi.
3. Yang CC, Deng JF (2007) Intermediate syndrome following organophosphate 
insecticide poisoning. J Chin Med Assoc 70: 467-472.
4. Jayawardane P, Dawson AH, Weerasinghe V, Karalliedde L, Buckly NA, 
et al.  (2008) The spectrum of intermediate syndrome following acute 
organophosphate poisoning: a prospective cohort study from SriLanka. 
PLoSMedicine 5: 1143-1153.
5. Eddleston M, Mohamed F, Davies JO, Eyer P, Worek F, et al. (2006) Respiratory 
failure in acute organophosphorus pesticide self-poisoning. QJM 99: 513-522.
6. Eddleston M, Clark RF (2011) Insecticides: organic phosphorus compounds 
and carbamates. In Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank 
LR, et al. Goldfrank’s Toxicologic emergencies. Ninth edition Mc Graw Hill.
7. Jamil H (1990) Acute poisoning-a review of 1900 cases. JPMA 40: 131-133.
8. Khurram M, Mahmood N (2008) Deliberate self poisoning- experience at a 
medical unit. JPMA 58: 455-457.
9. Hussain AM, Sultan ST (2005) Organophosphorus insecticide poisoning: 
management in surgical intensive care unit. JCPSP 15:100-102.
